COVID-19 Expanded Access Template

March 19, 2020 Alerts and Newsletters

We are aware that many companies and health care providers are working to expedite the transfer of investigational drugs that may be helpful in treating patients suffering from COVID-19. Although these expanded access arrangements are not required to be and are not always documented in written agreements, there can be benefits to both parties (company and treatment provider) to memorializing the circumstances of the provision of an investigational drug.

To that end, we have created a simple Memorandum of Understanding template that may be useful to companies and providers seeking to document these arrangements quickly and efficiently in light of the current public health emergency. The template is intentionally streamlined and balanced, to capture the common denominator of terms that are often included in these agreements in a way that is reasonable for both parties. The template is drafted to focus on the provision of investigational drugs, as we understand drugs to be the primary expanded access treatment option at this stage of the pandemic. To the extent there is a demand for the expanded access use of investigational devices, this template can be modified (or we can tailor and re-circulate a device version). The template is also focused on the requirements for expanded access under the FDA’s regulations (21 C.F.R. § 312.300 et seq.) and would require modification for the provision of investigational drugs pursuant to the federal Right to Try Act.

Please note that this template is not intended as legal advice, and our circulation of this resource does not create an attorney-client relationship. We merely want to make as many tools available to the regulated community as we can during these challenging times.

Click here to download the Memorandum of Understanding template.

Firm Highlights

Publication/Podcast

Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition.

Health care attorney Paul Shaw co-authored Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition with Robert Griffith, published by the American Health Law Association (AHLA). Paul and Robert provide legal...

News

Verrill's Strategic Growth in Key Areas Shared in Mainebiz

On Monday, November 15th Verrill was listed as a Maine law firm who is innovating ways to hire talent in the Mainebiz article "Remote Work Changes Hiring Strategies for Some Maine Law Firms." The...

News

65 Verrill Attorneys Recognized by Best Lawyers® 2022, Including Eight Named Lawyers of the Year

(August 31, 2021) – 65 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2022 , including 8 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer in...

News

Verrill Adds Lead Prosecutor On Insys Case To Boston Office- Law360

On November 18, 2021 Law360 published the article "Verrill Adds Lead Prosecutor On Insys Case To Boston Office," featuring David Lazarus , a recent addition to the Health Care and Life Sciences group at...

News

High-Profile Former U.S. Department of Justice Prosecutor, David Lazarus, Joins Verrill’s Health Care and Life Sciences Practice

(November 29, 2021) – Verrill is pleased to welcome David Lazarus to the firm’s Boston office as a Partner in its nationally recognized Health Care & Life Sciences Group. Lazarus is a former Department...

Publication/Podcast

James Roosevelt, Jr. Published in ScienceDirect

Verrill attorney James Roosevelt Jr. was published in the February 2022 volume of ScienceDirect , a scientific, technical, and medical research publication. His article “A Federal Indian Health Insurance Plan: Fulfilling a Solemn Obligation...

Publication/Podcast

How Growing Cyber Scrutiny Affects Corporate Compliance

Verrill attorneys David Lazarus , Michael Fee , and Jeffery Smagula authored an article published in Law360 on December 3, 2021 entitled "How Growing Cyber Scrutiny Affects Corporate Compliance." In the article Lazarus, Fee...

News

Pair of Recent Victories Hearten Counsel for MassHealth Providers

Verrill attorney David G. Lazarus was recently mentioned in the Massachusetts Lawyers Weekly article "Pair of Recent Victories Hearten Counsel for MassHealth Providers." The article covers two appellate court decisions regarding the boundaries to...

News

The Boston Globe on Federal Prosecutor Joining Verrill

Contact Verrill at (855) 307 0700